Bullous pemphigoid-like reaction in a patient with metastatic melanoma receiving pembrolizumab and previously treated with ipilimumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bullous pemphigoid-like reaction in a patient with metastatic melanoma receiving pembrolizumab and previously treated with ipilimumab

Published:2016-11 Issue:4 Volume:57 Page:333-335
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australasian Journal of Dermatology

Author:

Lomax Anna J¹,Ge Ludi²,Anand Sunaina²,McNeil Catriona¹²³⁴,Lowe Patricia²⁴

Affiliation:

1. Chris O'Brien Lifehouse; Sydney New South Wales Australia

2. Royal Prince Alfred Hospital; Sydney New South Wales Australia

3. Melanoma Institute Australia; Sydney New South Wales Australia

4. University of Sydney; Sydney New South Wales Australia

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12484/fullpdf

Reference11 articles.

1. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N. Engl. J. Med.,2015

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N. Engl. J. Med.,2010

3. Tumor immunotherapy directed at PD-1;Ribas;N. Engl. J. Med.,2012

4. Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies;O'Day;Cancer,2007

5. Management of immune-related adverse events and kinetics of response with ipilimumab;Weber;J. Clin. Oncol.,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid;Frontiers in Oncology;2023-03-03

2. Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer;JAMA Dermatology;2022-08-01

3. Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients—Focus on Clinical and Histopathological Variation;Dermatopathology;2022-03-18

4. Cutaneous adverse reactions to anti–PD-1 treatment—A systematic review;Journal of the American Academy of Dermatology;2020-11

5. Nivolumab-induced severe bullous pemphigoid in a patient with renal cancer: a case report and literature review;Journal of Cancer Metastasis and Treatment;2020-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3